Explore therapeutic choices for patients with treatment-resistant depression, including ketamine, psilocybin, and various ...

Depression is partially genetic meaning that you are more likely to suffer from it if someone from your family does, too.

Millions of Americans are living with major depressive disorder, a leading cause of disability with lasting personal and economic impacts.

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Leanne M. Williams ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks ...